Ultragenyx Announces Orphan Drug Designation for UX701 for the Treatment of Wilson Disease December 9, 2020
Vestwell Partners with Envestnet to Offer Turnkey Retirement Plan Solutions to Industry Advisors December 9, 2020
Orchard Therapeutics Reports OTL-201 Initial Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA) December 8, 2020
Checkmate Pharmaceuticals Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate CMP-001 in Combination with Nivolumab December 8, 2020
Innovent Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas December 7, 2020
Precision BioSciences Reports Positive Interim Results from PBCAR0191 Phase 1/2a Trial in Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) and R/R B-cell Acute Lymphoblastic Leukemia (B-ALL) December 4, 2020